| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Obesity
A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 14.47 | 10 | 3 |
Deep Vein Thrombosis
[description not available] | 0 | 4.45 | 1 | 1 |
Hyperphagia
Ingestion of a greater than optimal quantity of food. | 0 | 4.86 | 2 | 1 |
Weight Reduction
[description not available] | 0 | 9.04 | 6 | 4 |
Labhart-Willi Syndrome
[description not available] | 0 | 4.45 | 1 | 1 |
Prader-Willi Syndrome
An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229) | 0 | 4.45 | 1 | 1 |
Weight Loss
Decrease in existing BODY WEIGHT. | 0 | 9.04 | 6 | 4 |
Venous Thrombosis
The formation or presence of a blood clot (THROMBUS) within a vein. | 0 | 4.45 | 1 | 1 |
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 5.3 | 4 | 1 |
Diabetes Mellitus, Adult-Onset
[description not available] | 0 | 4.48 | 1 | 1 |
Diabetes Mellitus, Type 2
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. | 0 | 4.48 | 1 | 1 |
Cholera Infantum
[description not available] | 0 | 3.5 | 1 | 1 |
Adjustment Sleep Disorder
[description not available] | 0 | 3.5 | 1 | 1 |
Dyslipidemia
[description not available] | 0 | 3.03 | 1 | 0 |
Overweight
A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat. | 0 | 3.03 | 1 | 0 |
Blood Pressure, High
[description not available] | 0 | 3.03 | 1 | 0 |
Prediabetes
[description not available] | 0 | 3.03 | 1 | 0 |
Diabetes Mellitus
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. | 0 | 3.03 | 1 | 0 |
Hypertension
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. | 0 | 3.03 | 1 | 0 |
Prediabetic State
The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). | 0 | 3.03 | 1 | 0 |
Dyslipidemias
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL. | 0 | 3.03 | 1 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.47 | 2 | 0 |
Insulin Sensitivity
[description not available] | 0 | 2.15 | 1 | 0 |
Insulin Resistance
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. | 0 | 2.15 | 1 | 0 |
Cardiometabolic Syndrome
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY. | 0 | 4.45 | 1 | 1 |
Morbid Obesity
[description not available] | 0 | 4.45 | 1 | 1 |
Cardiovascular Diseases
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. | 0 | 4.45 | 1 | 1 |
Obesity, Morbid
The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. | 0 | 4.45 | 1 | 1 |
Metabolic Syndrome
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. | 0 | 4.45 | 1 | 1 |
Benign Neoplasms
[description not available] | 0 | 3.44 | 1 | 1 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 3.44 | 1 | 1 |
Disease Exacerbation
[description not available] | 0 | 3.46 | 1 | 1 |
Adenocarcinoma, Basal Cell
[description not available] | 0 | 3.46 | 1 | 1 |
Colorectal Cancer
[description not available] | 0 | 8.46 | 1 | 1 |
Adenocarcinoma
A malignant epithelial tumor with a glandular organization. | 0 | 3.46 | 1 | 1 |
Colorectal Neoplasms
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. | 0 | 3.46 | 1 | 1 |
Carcinoma, Lewis Lung
A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy. | 0 | 2.02 | 1 | 0 |
Hepatocellular Carcinoma
[description not available] | 0 | 2.02 | 1 | 0 |
Cancer of Liver
[description not available] | 0 | 2.02 | 1 | 0 |
Angiogenesis, Pathologic
[description not available] | 0 | 2.02 | 1 | 0 |
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 2.02 | 1 | 0 |
Liver Neoplasms
Tumors or cancer of the LIVER. | 0 | 2.02 | 1 | 0 |